Published in Lancet Neurol on March 01, 2007
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care (2011) 2.23
Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab (2010) 2.04
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Outcome prediction in mechanically ventilated neurologic patients by junior neurointensivists. Neurology (2010) 1.73
Use of T2-weighted magnetic resonance imaging of the optic nerve sheath to detect raised intracranial pressure. Crit Care (2008) 1.69
High critical care usage due to pediatric stroke: results of a population-based study. Neurology (2012) 1.56
Stem cells for ischemic brain injury: a critical review. J Comp Neurol (2009) 1.53
Health state preferences and decision-making after malignant middle cerebral artery infarctions. Neurology (2010) 1.52
Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab (2012) 1.39
Integrated systems of stroke care and reduction in 30-day mortality: A retrospective analysis. Neurology (2016) 1.38
Targeting astrocytes for stroke therapy. Neurotherapeutics (2010) 1.25
Decompressive craniectomy: past, present and future. Nat Rev Neurol (2013) 1.24
Optic nerve sheath diameter as a marker for evaluation and prognostication of intracranial pressure in Indian patients: An observational study. Indian J Crit Care Med (2014) 1.24
Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology (2009) 1.24
Design and validation of a prehospital scale to predict stroke severity: Cincinnati Prehospital Stroke Severity Scale. Stroke (2015) 1.20
Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke. J Stroke Cerebrovasc Dis (2012) 1.12
Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia. J Neurosci Res (2009) 1.10
Sonographic Optic Nerve Sheath Diameter as a Screening Tool for Detection of Elevated Intracranial Pressure. Emerg (Tehran) (2013) 1.07
Management of intracranial hypertension. Neurol Clin (2008) 1.07
Pupillary reactivity as an early indicator of increased intracranial pressure: The introduction of the Neurological Pupil index. Surg Neurol Int (2011) 1.04
Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol (2009) 1.02
Ocular sonography in patients with raised intracranial pressure: the papilloedema revisited. Crit Care (2008) 1.01
Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care (2014) 1.00
Aggressive care after a massive stroke in young patients: is that what they want? Neurocrit Care (2010) 0.99
Recognition and management of stroke in young adults and adolescents. Neurology (2013) 0.98
Case report of MR perfusion imaging in sinking skin flap syndrome: growing evidence for hemodynamic impairment. BMC Neurol (2010) 0.96
Data sharing among data monitoring committees and responsibilities to patients and science. Trials (2013) 0.96
Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals (Basel) (2013) 0.96
Pathophysiology of ischaemic stroke: insights from imaging, and implications for therapy and drug discovery. Br J Pharmacol (2007) 0.94
Clinical review: Therapy for refractory intracranial hypertension in ischaemic stroke. Crit Care (2007) 0.94
Managing malignant cerebral infarction. Curr Treat Options Neurol (2011) 0.93
A surgical model of permanent and transient middle cerebral artery stroke in the sheep. PLoS One (2012) 0.93
Cranioplasty with autologous cryopreserved bone after decompressive craniectomy: complications and risk factors for developing surgical site infection. Acta Neurochir (Wien) (2014) 0.90
Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations. Childs Nerv Syst (2010) 0.90
Advances in the management of intracerebral hemorrhage. J Neural Transm (Vienna) (2013) 0.90
Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial. Stroke (2014) 0.89
Pilot study of intravenous glyburide in patients with a large ischemic stroke. Stroke (2013) 0.88
Positive impact of pre-stroke surgery on survival following transient focal ischemia in hypertensive rats. J Neurosci Methods (2012) 0.87
Challenges in the diagnosis and treatment of pediatric stroke. Nat Rev Neurol (2011) 0.87
Decompressive hemicraniectomy in severe cerebral venous thrombosis: a prospective case series. J Neurol (2011) 0.87
Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature. BMC Neurol (2014) 0.86
Clinical review: Imaging in ischaemic stroke--implications for acute management. Crit Care (2007) 0.86
Exploratory analysis of glyburide as a novel therapy for preventing brain swelling. Neurocrit Care (2014) 0.86
The "Skull Flap" a new conceived device for decompressive craniectomy/cranioplasty: Feasibility study on cadaver specimen. J Neurosci Rural Pract (2013) 0.85
Where will the next generation of stroke treatments come from? PLoS Med (2010) 0.84
Stroke management. Ann Indian Acad Neurol (2011) 0.84
Pediatric stroke. Childs Nerv Syst (2011) 0.84
Brain edema predicts outcome after nonlacunar ischemic stroke. Stroke (2014) 0.84
ACE inhibition reduces infarction in normotensive but not hypertensive rats: correlation with cortical ACE activity. J Cereb Blood Flow Metab (2010) 0.84
A simple brain atrophy measure improves the prediction of malignant middle cerebral artery infarction by acute DWI lesion volume. J Neurol (2014) 0.84
Endovascular mechanical thrombectomy in basilar artery occlusion: initial experience. J Cerebrovasc Endovasc Neurosurg (2013) 0.83
Neurological susceptibility to a skull defect. Surg Neurol Int (2014) 0.83
Outcome of decompressive craniectomy in comparison to nonsurgical treatment in patients with malignant MCA infarction. Springerplus (2014) 0.83
Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage. Stroke (2014) 0.83
Importance of proper patient selection and endpoint selection in evaluation of new therapies in acute stroke: further analysis of the SENTIS trial. J Neurointerv Surg (2013) 0.83
Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials. Surg Neurol Int (2014) 0.83
How often are patients with ischemic stroke eligible for decompressive hemicraniectomy? Stroke (2011) 0.83
Critical care for patients with massive ischemic stroke. J Stroke (2014) 0.83
Cognition after malignant media infarction and decompressive hemicraniectomy--a retrospective observational study. BMC Neurol (2011) 0.82
Emergency Neurological Life Support: Intracranial Hypertension and Herniation. Neurocrit Care (2015) 0.82
Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke. Neurocrit Care (2011) 0.82
Decompressive craniectomy following brain injury: factors important to patient outcome. Libyan J Med (2010) 0.82
Organized Comprehensive Stroke Center is Associated with Reduced Mortality: Analysis of Consecutive Patients in a Single Hospital. J Stroke (2013) 0.82
Decompressive surgery for malignant supratentorial infarction remains underutilized after guideline publication. J Neurol (2011) 0.82
Neurotoxic and cardiotoxic effects of cocaine and ethanol. J Med Toxicol (2009) 0.81
Use of perfusion imaging and other imaging techniques to assess risks/benefits of acute stroke interventions. Curr Atheroscler Rep (2013) 0.81
Reduced mortality and severe disability rates in the SENTIS trial. AJNR Am J Neuroradiol (2013) 0.81
A Cohort Study of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction: A Real-World Experience in Clinical Practice. Medicine (Baltimore) (2015) 0.80
Drug treatment of acute ischemic stroke. Am J Cardiovasc Drugs (2013) 0.80
Antiplatelet therapy, but not intravenous thrombolytic therapy, is associated with postoperative bleeding complications after decompressive craniectomy for stroke. J Neurol (2013) 0.80
Advances in the critical care management of ischemic stroke. Stroke Res Treat (2013) 0.80
Updated Korean Clinical Practice Guidelines on Decompressive Surgery for Malignant Middle Cerebral Artery Territory Infarction. J Stroke (2015) 0.80
Ischemia, Immunosuppression and Infection-Tackling the Predicaments of Post-Stroke Complications. Int J Mol Sci (2016) 0.80
Endovascular Therapy in Strokes with ASPECTS 5-7 May Result in Smaller Infarcts and Better Outcomes as Compared to Medical Treatment Alone. Interv Neurol (2015) 0.79
Neurologists as primary palliative care providers: Communication and practice approaches. Neurol Clin Pract (2016) 0.79
Assessing the benefits of hemicraniectomy: what is a favourable outcome? Lancet Neurol (2007) 0.79
Where are We Now with Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction? J Cerebrovasc Endovasc Neurosurg (2013) 0.79
CSF Volumetric Analysis for Quantification of Cerebral Edema After Hemispheric Infarction. Neurocrit Care (2016) 0.78
Biomarkers in neurocritical care. Neurotherapeutics (2012) 0.78
DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY - Registry (DESTINY-R): design and protocols. BMC Neurol (2012) 0.78
Feasibility of the custom-made titanium cranioplasty CRANIOTOP(®). Surg Neurol Int (2013) 0.78
Decompressive craniectomy for the treatment of malignant infarction of the middle cerebral artery. Sci Rep (2014) 0.78
Reduction of Midline Shift Following Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction. J Stroke (2016) 0.77
Delayed hypothermia in malignant ischaemic stroke. Neurol Sci (2011) 0.77
Stroke management. BMJ Clin Evid (2011) 0.77
Childhood hemorrhagic stroke: an important but understudied problem. J Child Neurol (2011) 0.77
Elevated Intracranial Pressure and Cerebral Edema following Permanent MCA Occlusion in an Ovine Model. PLoS One (2015) 0.77
Therapy in pediatric stroke. Eur J Pediatr (2012) 0.77
Decompressive surgery for cerebral oedema after stroke: evidence at last. Lancet Neurol (2007) 0.77
Life-saving decompressive craniectomy for diffuse cerebral edema during an episode of new-onset diabetic ketoacidosis: case report and review of the literature. Childs Nerv Syst (2010) 0.77
Cognitive outcome of survivors of space-occupying hemispheric infarction. J Neurol (2013) 0.76
Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke. Nat Commun (2015) 0.76
Glibenclamide for the treatment of ischemic and hemorrhagic stroke. Int J Mol Sci (2015) 0.76
Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials. Stroke Res Treat (2016) 0.76
Upregulation of neuronal zinc finger protein A20 expression is required for electroacupuncture to attenuate the cerebral inflammatory injury mediated by the nuclear factor-kB signaling pathway in cerebral ischemia/reperfusion rats. J Neuroinflammation (2016) 0.75
Commentary. J Neurosci Rural Pract (2012) 0.75
The "Skull Flap" a new conceived device for decompressive craniectomy experimental study on dogs to evaluate the safety and efficacy in reducing intracranial pressure and subsequent impact on brain perfusion. J Neurosci Rural Pract (2013) 0.75
Evidence-based neurocritical care. Neurohospitalist (2014) 0.75
Malignant MCA territory infarction in the pediatric population: subgroup analysis of the Greater Cincinnati/Northern Kentucky Stroke Study. Childs Nerv Syst (2012) 0.75
Decompressive craniectomy after unsuccessful intravenous thrombolysis of malignant cerebral infarction. Iran J Neurol (2014) 0.75
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet (2007) 10.74
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33
Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke (2004) 8.77
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet (2007) 7.27
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet (2007) 7.11
Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med (2010) 5.79
Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med (2014) 5.79
Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol (2010) 5.79
A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med (1991) 5.69
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 5.58
Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet (2009) 5.31
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med (2014) 5.25
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace (2013) 5.16
The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain (2007) 4.80
Family presence during cardiopulmonary resuscitation. N Engl J Med (2013) 4.74
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
Updated systematic review and meta-analysis of randomized clinical trials on the role of mechanical bowel preparation before colorectal surgery. Ann Surg (2009) 4.66
Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol (2009) 4.60
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain (2005) 4.59
Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med (2012) 4.37
Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet (2008) 4.14
Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet (2010) 4.07
Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet (2010) 4.06
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol (2008) 3.91
Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol (2009) 3.89
Cadasil. Lancet Neurol (2009) 3.88
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS (2006) 3.82
Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med (2006) 3.80
Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol (2011) 3.73
Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology (2008) 3.67
How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci (2007) 3.67
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol (2009) 3.66
Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke (2007) 3.59
Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke (2010) 3.53
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials (2010) 3.45
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA (2011) 3.40
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol (2012) 3.37
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol (2009) 3.36
New ischaemic brain lesions on MRI after stenting or endarterectomy for symptomatic carotid stenosis: a substudy of the International Carotid Stenting Study (ICSS). Lancet Neurol (2010) 3.35
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med (2009) 3.23
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 3.22
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21
Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol (2007) 3.19
Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet (2012) 3.14
Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology (2013) 3.13
Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke (2004) 3.07
STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J (2007) 3.03
Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke (2006) 3.03
Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology (2009) 3.01
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
Carotid artery stenosis: accuracy of noninvasive tests--individual patient data meta-analysis. Radiology (2009) 2.94
Decompressive craniectomy and early cranioplasty for the management of severe head injury: a prospective multicenter study on 147 patients. World Neurosurg (2011) 2.89
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol (2012) 2.80
The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol (2009) 2.78
Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes (2006) 2.77
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77
Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. JAMA (2009) 2.72
Fibered confocal fluorescence microscopy (Cell-viZio) facilitates extended imaging in the field of microcirculation. A comparison with intravital microscopy. J Vasc Res (2004) 2.66
Synergistic deleterious effect of hypoxemia and hypovolemia on microcirculation in intestinal villi*. Crit Care Med (2013) 2.65
Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke (2012) 2.64
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol (2009) 2.64
Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke (2007) 2.62
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke (2007) 2.56
Timing of birth and risk of multiple sclerosis: population based study. BMJ (2004) 2.56
Causes and predictors of death in cerebral venous thrombosis. Stroke (2005) 2.56
Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke (2007) 2.54
EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J (2013) 2.52
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab (2011) 2.48
The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke (2006) 2.43
Thunderclap headache. BMJ (2013) 2.43